Search Results
Site Search
February 2020 - Laboratory Genetics & Genomics - Insights
A 71 yr old female with a history of a central nervous system lymphoma, an allogenic stem cell transplant and graft versus host disease was tested for...
inflammatory-bowel-disease-diagnostic-testing-algorithm.pdf
YES <50 mcg/g <50 mcg/g Abnormal >50 mcg/g Normal ANCA present ASCA IgG and IgA absent ANCA absent ASCA IgG or IgA present ANCA absent ASCA IgG or IgA absent >120 mcg/g50-120 mcg/g NO Assessing a patient...
Find out how our sarcoma panel assesses gene mutations and fusions described in more than 50 types of soft tissue, bone, and other mesenchymal tumors....
July 2019 — Cardiovascular - Insights
A 50-year-old man who was known to have systemic hypertension developed sudden onset of severe back pain with associated diaphoresis. He lost...
Mayo Clinic’s Neuro-Oncology practice, the Division of Laboratory Genetics and Genomics tests about 50 brain tumors a week, and upwards of 1,500 brain tumors a year from all over the world....
Early-Onset IBD: Genetic Testing and Clinical Applications - Insights
Identification of early-onset IBD patients may enable tailored treatment and surveillance plans. With over 50 genes implicated in early-onset IBD, genetic testing should be included in the workup of children under...
Mayo Clinic Laboratories Critical Values / Critical Results List
Mayo Clinic Laboratories Critical Values / Critical Results List DEFINITION A Critical Value / Critical Result is defined as: A value/result that represents a pathophysiological state at such variance with normal (expected values) as...
What's New in Health Care Reform: Feb. 20 - Insights
Top highlights include: Flu shot kept about 50% from going to doctor, racial disparities in cancer incidence and survival rates are narrowing, having anesthesia once as a baby does not cause learning disabilities...
50th Anniversary Stories - Insights
than 3,500 assays, Mayo Clinic Laboratories has experienced significant changes since its inception 50 years ago. What has not changed, however, is our commitment to meeting the needs of the patient — wherever...
biomarker assay for Alzheimer’s disease, an accessible, highly accurate testing option for individuals age 50 and above who are experiencing mild cognitive impairment or early dementia. Positive test results can...
critical-values-semi-urgent-results-list.pdf
PURPOSE DEFINITON Test Report Name Age Critical Low Critical High Units Activated Partial Thromboplastin Time, Plasma Any – ≥ 150 sec Fibrinogen Any ≤ 60 – mg/dL 0 – 7 weeks ≤ 6.0 ≥ 24.0 g/dL > 7 weeks ≤ 6.0 ≥ 20.0 g/dL INR (International...
For more than 50 years, Mayo Clinic Laboratories has been providing meaningful results to individuals seeking genetic answers. Rare genetic disorders can be among the most difficult conditions to diagnose...
Units of Measurement - Mayo Clinic Laboratories
Units of Measure A list of common units used in the reporting of our assays has been defined. Refer to the table for these units as well as the recommended report abbreviations. Last updated: June 6, 2025...
Units of Measurement - Mayo Clinic Laboratories
Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...
Pathways Case Studies: February 2020 - Insights
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. Cases for February include the following sub-specialties: Anatomic Pathology,...
Mayo Clinic Laboratory and pathology research roundup: December 14 - Insights
This week’s research roundup features: Renal Neoplasia in Polycystic Kidney Disease: An assessment of Tuberous Sclerosis complex-associated Renal Neoplasia and PKD1/TSC2 contiguous gene deletion syndrome.
Cocaine and Metabolite - Mayo Clinic Laboratories
Cocaine and Metabolite Interpretation The presence of cocaine >LOQ indicates exposure to cocaine within 1 day prior to specimen collection. The presence of benzoylecgonine >LOQ...
COVID-19 weekly news: April 4-10 2022 - Insights
Topic's Include: Testing wastewater for COVID-19: The clearest path to understanding community infection, and the latest advice about COVID-19 boosters.
Emergency/Overdose - Mayo Clinic Laboratories
Emergency/Overdose This test is intended to manage an apparent overdose, intoxicated patient, or determine if a specific set of symptoms might be due to the presence of drugs. This test is designed...
Applying the Staffing-to-Workload Methodology: Identifying Daily Indirect Effort Needs - Insights
Mike Baisch, Principal Systems Engineer at Mayo Clinic, demonstrates how daily indirect effort tasks contribute to staffing plans and needs in the staffing-to-workload methodology.
Sudden cardiac death and episodes of fainting and seizures from long QT syndrome are significantly lower than previously thought when patients are diagnosed and treated at a specialty center dedicated to the treatment of genetic heart...
Dengue Virus: A Diagnostic Testing Update - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., talks about Mayo Clinic Laboratories’ serologic and molecular testing for the identification of infection with dengue virus. Dengue virus poses a significant public health threat worldwide....
MCLRequest for Supplies MC0748
MCLRequest Supplies Complete print Request Supplies Reset Form Client Information required Client Account Number Client Contact Phone Date
Test Updates - Mayo Clinic Laboratories
The latest test updates.
Calprotectin and Inflammatory Bowel Disease - Insights
The differential diagnosis for inflammatory bowel disease (IBD) includes irritable bowel syndrome (IBS). While the clinical presentation is similar, IBD is an inflammatory disease, while IBS is a noninflammatory disease. View this "Hot...
CPT Code Updates - Mayo Clinic Laboratories
Test Catalog AlgorithmsDownload Test Catalog & Interpretive HandbookNew TestsNY State Informed Consent TestsPerforming LocationsReferred TestsSpecialty TestingTest Updates...
lynch_syndrome_testing_algorithm.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. 03/2024 Lynch Syndrome Testing Algorithm Pathogenic variant identified Testing in family member was negative or variant of uncertain significance...
Maternal Screening - Mayo Clinic Laboratories
Share Print Web: mayocliniclabs.com...
Sarcoma NGS Testing - Mayo Clinic Laboratories
n order to aid in the diagnosis for a wide range of tumors, our sarcoma NGS panel includes fusions in 138 individual genes.
Learn how Mayo Clinic Laboratories’ outreach solutions can enhance and promote the clinical, business, and operational relevance of the hospital laboratory.
Ceramide testing provides algorithmic score for heart attack risk - Insights
Mayo Clinic Laboratories offers a ceremide test to advise patients and their clinicians of the potential risk of heart attack. Using liquid chromatography-mass spectrometry technology, the test renders an algorithmic score after sorting...
CNS Demyelinating Disease Testing - Mayo Clinic Laboratories
We offer the only FACS assay for CNS Demyelinating Disease. Our testing ensures the highest senstivity and specificity, providing the most accurate results for patients.
COVID-19 weekly news: April 11-17 2022 - Insights
Topics include: Why women's risk of heart disease increased during the pandemic and information about the most commonly asked questions for when to get your second COVID-19 booster.
IDH assay facilitates timelier leukemia treatment: Rong He, M.D. - Insights
In this test-specific episode of the "Answers From the Lab" podcast, Rong He, M.D., explains how Mayo Clinic Laboratories' IDHQ test improves upon next generation sequencing for assessing AML treatment options.
FDA-approved test expands options for Alzheimer's disease - Insights
Joshua Bornhorst, Ph.D., describes the new, FDA-approved Alzheimer's disease (AD) test and how it differs from Mayo Clinic Laboratories' existing AD evaluation. The laboratory will offer both tests, to ensure flexibility and options for...
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. AATHR / Thrombophilia Profile, Plasma and Whole Blood Testing begins with: ■ Prothrombin Time (PT), Plasma ■ Activated Partial Thromboplastin Time (APTT),...
Sarcoma Testing - Mayo Clinic Laboratories
Supplementing the histologic diagnosis with genetic testing can improve diagnostic accuracy and overall patient management.
Small Fiber Neuropathy: Diagnosis and Treatment - Insights
The considerations physicians must weigh when evaluating suspected neuropathy patients with special emphasis put on small-fiber neuropathy and the most appropriate laboratory testing related to that phenotype.
MCL Pricing Custom Gene Ordering MC4091141
MCL Pricing Custom Gene Ordering Custom Gene Panel Ordering Pricing Tiers CGPH Custom Gene Panel Hereditary Generation Sequencing NGS Varies Explanation Pricing
MCL Pricing Custom Gene Ordering MC4091141
MCL Pricing Custom Gene Ordering Custom Gene Panel Ordering Pricing Tiers CGPH Custom Gene Panel Hereditary Generation Sequencing NGS Varies Explanation Pricing
Curtis Hanson, M.D., Discusses Prognostic Markers for Chronic Lymphocytic Leukemia - Insights
Curtis Hanson, M.D., discusses the importance of detecting immunoglobulin heavy-chain variable region gene (IGHV) when acquiring prognostic and potentially therapeutic information in chronic lymphocytic leukemia (CLL) patients in CAP TODAY.
Plasma Test Increases Access to Alzheimer's Testing: Alicia Algeciras-Schimnich, Ph.D. - Insights
Plasma Test Increases Access to Alzheimer’s Testing: Alicia Algeciras-Schimnich, Ph.D. Answers From the Lab In this episode of “Answers From the Lab,”
Innovative Alzheimer's disease diagnostic tool unveiled - Insights
Mayo Clinic Laboratories has marked a significant advancement in the fight against Alzheimer's disease with the introduction of an innovative diagnostic test. This noninvasive blood test accurately detects the p-Tau217 biomarker, indicative...
People Archives - Page 27 of 35 - Insights
Skip to Content MayoACCESS MayoLINK...
Mayo Clinic Laboratory and Pathology Research Roundup: November 7, 2023 - Insights
This week's research roundup feature: Cytomegalovirus (CMV) is a significant cause of morbidity and mortality among immunocompromised hosts, including transplant recipients. Antiviral prophylaxis or treatment is used to reduce the incidence...
Manage to Reimbursement - Insights
PACE/State of FL - This webinar will provide a methodology for laboratory leadership to review their test menu for assays that most impact the financial health of their laboratory.
HCV Treatment_(Interferon-Free).indd
05/2019© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Chronic Hepatitis C Treatment and Monitoring Algorithm: Direct Antiviral Agent (DAA) Combination * www.hcvguidelines.org Treatment failure STOP...
What's New in Health Care Reform: Dec. 5 - Insights
Top highlights include: Minnesota OKs medical marijuana to treat Alzheimer's, U.S. life expectancy declines again, polio-like disease in U.S. kids appears to have peaked for 2018, methamphetamine use by pregnant women, and the effects of...
Feb. 1986: Mayo Clinic's Year-Old Liver Transplant Program - Insights
In 1986, Mayo Clinic's year-old liver transplant program was growing to be one of the largest in the world. Take a step back to 1986 by reading this article from the February issue of Mayovox.
Then and now: Upholding Mayo Clinic's core values - Insights
Part two of the 50th Anniversary series highlights how Mayo Clinic Laboratories has remained focused on our core values through support of Mayo Clinic’s three shields – integrated clinical practice, research, and education.